Emicizumab Prophylaxis in Hemophilia A with Inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Emicizumab Prophylaxis in Hemophilia A with Inhibitors

Published:2017-08-31 Issue:9 Volume:377 Page:809-818
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Oldenburg Johannes,Mahlangu Johnny N.,Kim Benjamin,Schmitt Christophe,Callaghan Michael U.,Young Guy,Santagostino Elena,Kruse-Jarres Rebecca,Negrier Claude,Kessler Craig,Valente Nancy,Asikanius Elina,Levy Gallia G.,Windyga Jerzy,Shima Midori

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa1703068

Cited by 850 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient and Caregiver Preferences for Hemophilia A Treatment in Taiwan: A Discrete Choice Experiment;Value in Health Regional Issues;2025-01

2. Emicizumab and unmet needs of patients with hemophilia a who are managed with replacement therapies;Expert Review of Hematology;2024-09-12

3. Enhanced procoagulant activity of select hemophilia B causing factor IX variants with emicizumab;Blood;2024-09-12

4. Perioperative Management for Port Catheter Procedures in Pediatric Patients with Severe Hemophilia and Inhibitors;Hämostaseologie;2024-09-12

5. Improved prevention of bleeding episodes with emicizumab in 3 patients with concomitant hemophilia A and von Willebrand disease;Blood Coagulation & Fibrinolysis;2024-09-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP